$CTS

O'SULLIVAN KIERAN M sold $4.0M of CTS

O'SULLIVAN KIERAN M (President & CEO) sold 60,388 shares of CTS CORP (CTS) at $66.26 ($4.00M total) on 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · O'SULLIVAN KIERAN M
Published Jun 3, 2026, 9:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 9:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CTS
Neutral
medium confidence
Mentioned
$CTS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CTSNeutralLow
01

Why it matters

The disclosure provides incremental information about insider activity but does not introduce new company fundamentals (no earnings, guidance, deal, or regulatory action).

02

Market read

Primarily a sentiment/positioning datapoint; likely low incremental trading signal given 10b5-1 context.

03

What to watch

Traders may overreact without checking whether multiple insider trades occurred around the same period or whether the plan is routine/recurring.

Relevance 6/10Novelty 6/10Timing: SEC Form 4 filed June 3 for a June 2 sale

Background

The filing is an SEC Form 4 insider transaction: CTS Corp’s President & CEO sold shares in an open-market transaction under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$CTSNeutralMedium confidence
Context

CTS Corp CEO sold 60,388 shares in an open-market transaction disclosed via SEC Form 4 on June 2 under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect is more about sentiment/positioning than new fundamentals.

Evidence & confidence

This is an ownership-change disclosure with no accompanying operational or financial catalyst; 10b5-1 typically dampens interpretability.

Market effects

Minimal—single-company insider transaction without sector-wide news.

Minimal—no geographic or cross-border catalyst mentioned.

Minimal—no global deal/regulatory/operational update included.

Counterpoint

Even with a 10b5-1 plan, the sale size ($4.0M) could still reflect planned liquidity needs rather than bearish expectations; price impact may be overstated.

Key entities

  • CTS CORP

    Subject of the SEC Form 4 insider sale by the President & CEO.

  • O'Sullivan Kieran M

    President & CEO who sold 60,388 shares at ~$66.2627/share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CTSMedAI 8/10

CTS Corporation Q2 2026 Earnings Call Summary

CTS Corporation reported Q2 2026 gross margin of 41.5% and said diversified end markets now make up 59% of revenue. Medical sales grew 45% YoY, industrial rose 16%, while transportation fell 2%. Full-year 2026 sales guidance was raised to $565-$585 million. Management expects aerospace strength in H2 and cautions on tariffs and precious metal inflation.

$CTSMedAI 8/10

Why CTS (CTS) Stock Is Up Today

CTS Corporation (NYSE: CTS) shares rose about 5.8% after the company reported Q2 results that beat expectations and raised full-year guidance. CTS said sales were $144.8 million (+7% YoY) and adjusted EPS was $0.74. It now expects 2026 revenue around $575 million (midpoint) and adjusted EPS of $2.63 (midpoint).

$CTSHigh

CTS CORP (CTS): Results of Operations and Financial Condition

CTS CORP (CTS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cts-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 July 28, 2026 FOR IMMEDIATE RELEASE CTS Announces Second Quarter 2026 Results Strong diversification momentum drives record margins and profitability; 2026 outlook raised Lisle, Ill. - CTS Corporation (NYSE: CTS), a leading gl

$CTSMed

ASX Runners of the Week: Ceretas, Pacgold & Hamelin Gold

The article links Middle East tensions to a jump in oil prices, with Brent up about 15% above US$100. It also cites Australia’s June employment gain of 76,300 and unemployment at 4.4%. ASX “runners” include Ceretas Ltd (CTS), up 142% after an $8m IPO for portable ultrasound in Alzheimer’s trials, and Pacgold Ltd (PGO), up 82% after high-grade copper-gold results at White Dam.